Contact Form

Please fill in the form below, or if you prefer, contact us directly:

Genetic Engineering & Biotechnology News
140 Huguenot Street, 3rd Floor
New Rochelle, NY 10801-5215 USA
Phone (914) 740-2100
Fax (914) 740-2201 or toll free 1-800-7999-GEN

* Required

CAREER CENTER

visit the Career Center

WEBINARS

GEN Webinars: Overcoming LC/MS Data Overload in Biotherapeutic Characterization
Date: Wednesday, November 18, 2009
The most significant challenge for efficient biotherapeutic protein characterization is not the acqu ...learn more.

view all webinars

GEN and Scintellix bring you the Cryptogram Challenge: ELISA REDUX!

PODCASTS

INTERVIEW: NANOTECHNOLOGISTS CREATE ARTIFICIAL PORE - Interview with Peixuan Guo, Ph.D., Director of the NIH Nanomedicine Development Center at the University of Cincinnati, Endowed Chair, and Professor of Biomedical Engineering ...MORE

MOST POPULAR

News

Most Viewed	Most Emailed	Top Searches
Thermo Fisher Scientific Launches Biomarker Test for Heart Attack in Europe
Preliminary Data on Genta’s Melanoma Drug Sends Firm Crashing
FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pa...
Investigators Propose Explanation for Flu Virus Antigenic Drift
Arena Reports Positive Data from Phase III Trial with Obesity Therapy
FDA Grants Emergency Use Authorization to Gen-Probe's PCR Test for the H1N1 Flu

Most Viewed	Most Emailed	Top Searches
Novartis to Invest $1.25B in Two New Facilities in China
Investigators Propose Explanation for Flu Virus Antigenic Drift
Novartis to Buy 85% of Chinese Vaccines Company for $125M
Drug could provide first treatment for scleroderma
PPD to Spin Out Compound-Partnering Segment, Acquire Chinese CRO, and Invest $100M in Celt...
Researchers Elucidate How Bone Marrow Derived Stem Cells Can Be Used in Acute Lung Injury

Most Viewed	Most Emailed	Top Searches
Investigators Propose Explanation for Flu Virus Antigenic Drift
Preliminary Data on Genta’s Melanoma Drug Sends Firm Crashing
Novartis to Buy 85% of Chinese Vaccines Company for $125M
Researchers Create iPSCs from Somatic Cells without Exogenous Transcription Factors
Roche’s Initial Phase III Trial Finds Taspoglutide Better than Byetta in Type 2 Diabetes
Novartis Starts Shipment of Seasonal Flu Vaccine to the U.S.

Articles

Most Viewed	Most Emailed	Top Searches
Searching for Appropriate Cancer Biomarkers
Certainty Not Required for Inventorship
Firms Seek to Prove Cancer Stem Cell Hypothesis
High-Content Screening Surges Ahead
Cells That Get No Respect
Search Intensifies for Diabetes Drugs

Most Viewed	Most Emailed	Top Searches
Certainty Not Required for Inventorship
Animal Imaging Transforms Development
Third Option for Stem Cell Research Emerges
Searching for Appropriate Cancer Biomarkers
EcoBiotics Scours Rainforest for Compounds
Stem Cell Technologies Boost Regenerative Medicine

Most Viewed	Most Emailed	Top Searches
Searching for Appropriate Cancer Biomarkers
Funding Embryonic Stem Cell Research
EcoBiotics Scours Rainforest for Compounds
Cells That Get No Respect
POINT OF VIEW: Genetically Modified Foods Unsafe? Evidence that Links GM Foods to Allergic...
Human Genome-Wide Association Studies

Blogs

Most Viewed	Most Emailed	Top Searches
New Recommendations for Gene Patents - Thank Goodness!
Genetically Modified Foods Debate
Mitochondrial Gene Defects and Disorders
Making the Right Decisions in a Recession
Healthcare Reform - Who Hasn't Been Included in the Discussion
Biomolecular Computation

Most Viewed	Most Emailed	Top Searches
BIO-Europe 2009 Day 3
New Recommendations for Gene Patents - Thank Goodness!

Most Viewed	Most Emailed	Top Searches
H1N1 Influenza vaccine manufacturers ramp up for October 15
Genetically Modified Foods Debate
Dr. James Watson Controversy
Genetically Modified Foods - The Benefits
H1N1 Swine Flu activity picks up; vaccine roll-out under way
Mitochondrial Gene Defects and Disorders

Name:	*
Position:
Institution/affiliation:
Department:
Address:	*
Address 2:
City/town:	*
Country:	*
State/province:	*
ZIP/postal code:
E-mail:	*
Confirm e-mail:	*
Phone:	--ext. * *
Fax:	--
Question regarding:	*
Question:*

CURRENT ISSUE

SUBSCRIBE

AD LINK

Contact Form

CAREER CENTER

WEBINARS

PODCASTS

MOST POPULAR

News

Articles

Blogs

CURRENT ISSUE

SUBSCRIBE

AD LINK

Contact Form

CAREER CENTER

Visit the GEN Career Center

WEBINARS

PODCASTS

MOST POPULAR

News

Articles

Blogs